mutant p53 peptide pulsed dendritic cell vaccine

BIOLOGICAL3 trials

Sponsors

National Cancer Institute (NCI), Robert Ferris

Conditions

Breast CancerCervical CancerColorectal CancerHead and Neck CancerLung CancerOvarian CancerPancreatic Cancer

Phase 1

Vaccine Therapy in Treating Patients With Head and Neck Cancer

CompletedNCT00404339

Robert FerrisHead and Neck Cancer

Start: 2005-09-30End: 2014-03-31Updated: 2016-04-18

Phase 2

Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

CompletedNCT00019929

National Cancer Institute (NCI)Lung Cancer

Start: 2000-08-31End: 2005-12-31Updated: 2013-06-20

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

CompletedNCT00019084

National Cancer Institute (NCI)Breast Cancer, Cervical Cancer, Colorectal Cancer +3

Start: 1996-02-29End: 2003-05-31Updated: 2013-06-20